trans-Clopenthixol (dihydrochloride)
Product Specifications
UNSPSC Description
trans-Clopenthixol ((E)-Clopenthixol) dihydrochloride is an antibiotic agent, without neuroleptic effect. trans-Clopenthixol can be used to inhibit Pseudomonas aeruginosa and Plasmodium falciparum in vitro[1][2].
Target Antigen
Antibiotic; Bacterial; Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/trans-clopenthixol-dihydrochloride.html
Purity
99.98
Solubility
DMSO : 10 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
OCCN(CC1)CCN1CC/C=C2C3=CC(Cl)=CC=C3SC4=CC=CC=C4/2.[H]Cl.[H]Cl
Molecular Weight
473.89
References & Citations
[1]Kristiansen JE, et al. The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis(Z)- and trans(E)-clopenthixol. Acta Pathol Microbiol Immunol Scand B. 1985 Jun;93(3):249-51.|[2]Kristiansen J E, et al. Stereo-isomeric dissociation of the antibacterial and the neuroleptic effect of clopenthixol[J]. Acta pathologica et microbiologica Scandinavica. Section B, Microbiology, 1981, 89(6): 437-438.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-A0163C/trans-Clopenthixol-dihydrochloride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-A0163C/trans-Clopenthixol-dihydrochloride-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
58045-22-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7066912 Inquire
Recombinant Yersinia pseudotuberculosis serotype IB Sulfoxide reductase heme-binding subunit YedZ (yedZ), partial
Ask
View Details